Cargando…
Non-Viral Gene Therapy in Trabecular Meshwork Cells to Prevent Fibrosis in Minimally Invasive Glaucoma Surgery
The primary cause of failure for minimally invasive glaucoma surgery (MIGS) is fibrosis in the trabecular meshwork (TM) that regulates the outflow of aqueous humour, and no anti-fibrotic drug is available for intraocular use in MIGS. The myocardin-related transcription factor/serum response factor (...
Autores principales: | Luo, Jinyuan, Tan, Greymi, Thong, Kai Xin, Kafetzis, Konstantinos N., Vallabh, Neeru, Sheridan, Carl M., Sato, Yusuke, Harashima, Hideyoshi, Tagalakis, Aristides D., Yu-Wai-Man, Cynthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693853/ https://www.ncbi.nlm.nih.gov/pubmed/36432663 http://dx.doi.org/10.3390/pharmaceutics14112472 |
Ejemplares similares
-
Novel PEGylated Lipid Nanoparticles Have a High Encapsulation Efficiency and Effectively Deliver MRTF-B siRNA in Conjunctival Fibroblasts
por: Sanghani, Amisha, et al.
Publicado: (2021) -
Minimally Invasive Glaucoma Surgery—to Remove or Preserve the Trabecular Meshwork: That is the Question?
por: Dada, Tanuj, et al.
Publicado: (2021) -
An Optimized Method to Decellularize Human Trabecular Meshwork
por: Crouch, Devon J., et al.
Publicado: (2022) -
Histological Findings in the Trabecular Meshwork of a Patient with Atopic Glaucoma
por: Kase, Satoru, et al.
Publicado: (2017) -
Investigating the Relationship between Glaucoma Prevalence and Trabecular Meshwork Length
por: Choi, Wungrak, et al.
Publicado: (2021)